Drug recall · December 6, 2017
Clozapine Tablets USP recall
Why: Failed Tablet/Capsule Specifications; potential presence of broken tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clozapine Tablets USP, 100 mg, 500 count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICALS IND, LTD, Jerusalem Israel, Manufactured For: TEVA PHARMACEUTICALS USA, North Wales, PA, NDC 00093-7772-05
- Lots / codes
Lot # 39C192, exp 06/2019
- Quantity
- 3,870 bottles
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- Nationwide
- Initiated
- November 9, 2017 · Voluntary: Firm initiated
- Classified
- November 27, 2017
- Reported
- December 6, 2017
- Ended
- July 3, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clozapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.